PMID: 9535457Apr 16, 1998Paper

Lobectomy combined with volume reduction for patients with lung cancer and advanced emphysema

The Journal of Thoracic and Cardiovascular Surgery
S R DeMeesterJ D Cooper

Abstract

Early-stage lung cancer is best treated by anatomic pulmonary resection. Patients with lung cancer and severe emphysema are often denied resection or are offered only limited, nonanatomic resections when established pulmonary function criteria for lobectomy are not met. Recently, with the introduction of the volume reduction operation, selected patients with disabling emphysema have undergone excision of approximately 30% of the most destroyed lung tissue and have subsequently demonstrated subjective and objective improvement in pulmonary function. Using these principles, we elected to combine anatomic lobectomy with volume reduction in a select group of patients with both emphysema and lung cancer who would not otherwise be candidates for pulmonary resection. Five patients with severe emphysema and suspected or proven lung cancers, who were poor candidates for anatomic lobectomy by traditional criteria but were good candidates for volume reduction, underwent lobectomy combined with volume reduction of one or more additional lobes. All five patients having lung volume reduction and anatomic lobectomy for early-stage primary lung cancer did well postoperatively. Furthermore, each patient has demonstrated subjective and objective...Continue Reading

References

Feb 1, 1986·The American Journal of the Medical Sciences·W C Vial
Jan 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·J D CooperC L Roper
Nov 1, 1993·World Journal of Surgery·A Bezjak, D Payne
Oct 20, 1993·International Journal of Radiation Oncology, Biology, Physics·L KaskowitzC Rush
Jan 1, 1993·Chest·J M Samet
Jan 1, 1996·The Annals of Thoracic Surgery·F A PigulaR J Landreneau
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·H A GaissertG A Patterson
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·R J KeenanC M Bowers
Nov 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·J D CooperS S Lefrak

❮ Previous
Next ❯

Citations

Dec 3, 2003·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Kiyoshi KoizumiShigeo Tanaka
Feb 5, 2000·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·K HayashiM Takeshita
Dec 12, 2003·The Annals of Thoracic Surgery·Eugenio PompeoTommaso C Mineo
Sep 27, 2001·Anesthesiology Clinics of North America·P D Slinger, M R Johnston
Jul 1, 1999·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A CarrettaS Bianco
May 4, 2000·Journal of Cardiothoracic and Vascular Anesthesia·P D Slinger, M R Johnston
Jul 17, 1999·Current Opinion in Pulmonary Medicine
Feb 27, 2001·Current Opinion in Pulmonary Medicine·F C Cordova, G J Criner
Jun 14, 2003·Current Opinion in Pulmonary Medicine·Chris Thomas Bolliger
May 6, 2008·Proceedings of the American Thoracic Society·Namrata PatelGerard J Criner
Aug 9, 2001·Seminars in Thoracic and Cardiovascular Surgery·B H Culver
Jul 22, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kosuke KashiwabaraHirotsugu Kohrogi
Jan 16, 2003·Chest·Michael A BecklesUNKNOWN American College of Chest Physicians
Sep 4, 2010·Seminars in Thoracic and Cardiovascular Surgery·Wael N Yacoub, Bryan F Meyers
Aug 11, 2009·Thoracic Surgery Clinics·Cliff K ChoongJoel D Cooper
Nov 26, 2005·The Journal of Thoracic and Cardiovascular Surgery·Sergio BaldiPiero Zannini
Sep 24, 2004·Thoracic Surgery Clinics·Jocelyne Martin
Nov 7, 2003·The Annals of Thoracic Surgery·J Ryan BurkeJoseph I Miller
Apr 30, 2004·The Journal of Thoracic and Cardiovascular Surgery·Cliff K ChoongJoel D Cooper
Feb 18, 2010·Clinical Pulmonary Medicine·Kristy Bauman, Douglas Arenberg
Apr 14, 2010·Expert Review of Respiratory Medicine·Peter J Mazzone
Jul 17, 1999·Current Opinion in Pulmonary Medicine·G A Lillington
Jan 18, 2021·Journal of Cardiothoracic and Vascular Anesthesia·Ciara HanleyPeter Slinger
Jan 15, 2002·Clinics in Chest Medicine·C A Powell, C E Caplan
Feb 24, 2001·Clinics in Chest Medicine·K R Flaherty, F J Martinez
Sep 24, 2004·Thoracic Surgery Clinics·Ibrahim Bulent CetindagStephen R Hazelrigg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.